Schulich school of Medicine and Dentistry logo Schulich Medicine & Dentistry Research Office


working on test tubes

Latest funding opportunities listed:

American Fibromyalgia Syndrome Association

AFSA funds research that investigates the causes and treatments for fibromyalgia syndrome (FMS).

Deadline for letter of intent: Continuous

Read More

Angelman Syndrome Foundation, Inc.

The ASF announces the availability of funding in support of research on Angelman syndrome. Angelman syndrome is a neurodevelopmental disorder caused by deficiency of the ubiquitin protein ligase UBE3A in the brain. Applications in the preclinical, translational and clinical research areas that investigate all aspects of Angelman syndrome will be considered. Highest priority will be given to pilot projects to test new ideas about pathogenesis and therapeutics of Angelman syndrome.

Deadline: October 15, 2014

Read More

BrightFocus Foundation - Alzheimer's Disease Research

BrightFocus provides research funds for U.S. domestic as well as international researchers pursuing pioneering research leading to a greater understanding of Alzheimer’s disease.

Deadline: October 14, 2014

Read More

BrightFocus Foundation - National Glaucoma Research

The standard award provides significant funding for researchers who have already generated some amount of preliminary data, but often still require significant progress before they can apply to governmental or industrial funding agencies.

Deadline: November 4, 2014

Read More

CDQM/OCE Explore Program

CQDM and the Ontario Centres of Excellence (OCE) are working collaboratively to launch the 2014 Explore competition which aims to support unconventional and highly innovative research projects that could strongly impact the drug discovery process. Explore is designed to fund early concept validation of cutting edge technologies, computational tools, novel approaches, techniques and devices that address the most crucial needs in drug discovery and/or development.

Deadline for letter of intent: September 25, 2014

Read More

CIHR - Knowledge Synthesis Grant : Fall 2014 Competition

All forms of knowledge synthesis are eligible, including systematic reviews, realist syntheses, narrative syntheses, meta-analyses, meta-syntheses and meta-ethnography. Syntheses that are intended to lead to the development of practice guidelines are also eligible. Syntheses in this funding opportunity may synthesize results from qualitative, quantitative or multi-method research. The types of knowledge than can be synthesized are broad and can include empirical as well as theoretical knowledge. All syntheses in this funding opportunity must assemble, analyse and summarize knowledge.

Deadline: November 17, 2014

Read More

CIHR - Operating Grant : Industry-Partnered Collaborative Research Program (Fall 2014)

The Industry-Partnered Collaborative Research Operating Grant program provides funding for collaborative research projects involving the academic community and Canadian industry partners sharing an interest in health R&D. The research planned should be beneficial to both parties, while improving the quality of health of Canadians. Projects may be initiated by either party; however, the academic researcher is responsible for applying for the grant.

Deadline for Registration: August 15, 2014

Read More

CIHR - Partnerships for Health System Improvement : 2014-2015 (PHSI)

The intent of the Partnerships for Health System Improvement (PHSI) program is to strengthen Canada's healthcare system through collaborative, applied and policy-relevant research. PHSI is Canada's premier health services and policy research competition - and with its strong emphasis on partnerships and knowledge translation it is also a major resource for managers and policy makers who want relevant research to inform their decision-making. PHSI funds teams of decision makers and researchers to conduct applied health services and policy research. Because they participate throughout the research process the research results are more likely to be relevant to and used by decision makers.

Deadline: October 15, 2014

Read More

Cystic Fibrosis Canada

"In the fall of 2014, Cystic Fibrosis Canada is accepting applications in the following categories: Discovery research grants in CF1; Clinical research grants in CF2; Early Career Investigator award in CF3; Fellowship and Studentship awards. "

Deadline for notice of intent: August 11, 2014

Read More

Epilepsy Foundation - New Therapy-Commercialization Grants Program

The mission of the New Therapy - Commercialization Grants Program is to drive the development of new therapies for epilepsy, accelerating the advancement of research from the laboratory to the patient.

Deadline for Letter of Intent: August 15, 2014

Read More

Epilepsy Foundation of America - Epilepsy Innovation Seal of Excellence Award

The Epilepsy Innovation Seal of Excellence awards are designed to accelerate the advancement of research from the laboratory to the patient. The program seeks to advance the development of new therapies including but not limited to medicines, biologics or devices. All proposals must demonstrate a clear path from the lab to the patient and are evaluated with consideration for their potential value to patients, likelihood of successful development including regulatory approval and the timeframe of development. Drug development may be stimulated at the early phases leading to an IND.

Deadline for letter of intent: August 15, 2014

Read More

Families of SMA - Research Projects on Spinal Muscular Atrophy

Families of SMA would like to encourage applications on novel research that will enhance our understanding of SMA disease pathology at the molecular, cellular, and biochemical level; generate key reagents and tools to facilitate drug development and clinical trials; and identify new therapeutic strategies for SMA.

Deadline: September 5, 2014

Read More

Foundation Leducq - Transatlantic Networks of Excellence

Under the Transatlantic Networks of Excellence in Cardiovascular Research Program the Fondation Leducq awards grants of up to U.S. $6,000,000 over five years for internationally collaborative research in cardiovascular and neurovascular disease.

Deadline for Letter of Intent: September 5, 2014

Read More

Genentech Age-Related Macular Degeneration Research Fellowships

The ARVO Foundation will offer one grant to a researcher working in basic research in the understanding of AMD and another grant to a researcher working in translational AMD research focusing on therapeutics.

Deadline: September 30, 2014

Read More

Immune Tolerance Network - RFP: Clinical Trials of Immune Tolerance in Transplantation Using Deceased-Donor Organs

The Immune Tolerance Network is currently seeking proposals for clinical tolerance trials in transplantation using solid organs or islets from deceased donors. Proposals should meet the following criteria: 1. There is strong support with preclinical data and/or evidence from clinical pilot studies; if preclinical studies alone are used to support the proposal, these studies should include brain dead donors or discuss why such studies are not needed with the proposed protocol. 2. The donor and recipient are HLA mismatched. 3. Biomarker use and/or discovery should be incorporated into the immunosuppression withdrawal plan.

Deadline ofr Letter of Inquiry: August 29, 2014

Read More

International Foundation for Research in Paraplegia

Projects submitted for consideration must be focused on basic or clinical research into paraplegia or related fields.

Deadline: October 31, 2014

Read More

Meso Foundation

The Meso Foundation (formerly known as the Mesothelioma Applied Research Foundation [MARF]) saves lives by funding critical research in prevention, early detection, and treatment development. The Meso Foundation is calling for applications for available mesothelioma research funding.

Deadline: August 08, 2014

Read More

Michael J. Fox Foundation for Parkinson's Research Target Validation Program

The Target Validation program supports work aiming to determine whether manipulation of a defined biological target provides a disease-relevant beneficial outcome in a whole animal, mammalian model of PD.

Deadline for Pre-proposals: October 29, 2014

Read More

Michael J. Fox Foundation for Parkinson's Research Therapeutic Pipeline Program

The Therapeutic Pipeline Program supports PD therapeutic development along the entire preclinical and clinical path. Although MJFF is open to any creative therapeutic strategy, ideal applications should focus on efforts to address one of the following treatment challenges: Strategies that protect or restore degenerating and/or dysfunctional neurons affected in PD; Strategies to alleviate disabling motor and non-motor symptoms of PD. (Important non-motor symptoms include cognitive dysfunction/dementia, depression/mood disorders, autonomic dysfunction and sleep disorders); Strategies to alleviate complications of PD treatment including dyskinesias and other disabling side effects.

Deadline for Pre-proposals: October 29, 2014

Read More

Michael J. Fox Foundation for Parkinson's Research  - Rapid Response Innovation Awards

"Part of the annual Edmond J. Safra Core Programs for PD Research, the Rapid Response Innovation Awards (RRIA) program supports high-risk, high-reward projects with little-to-no existing preliminary data, but with potential to significantly impact our understanding of Parkinson's disease (PD). Moreover, this program is well-suited for early exploratory studies that may open the field up to new targets or pathways that may ultimately feed the early drug development pipeline for a treatment of PD. "

Deadline: Continuous

Read More

MITACS - Accelerate InDev Program

Mitacs Accelerate connects companies with research-based universities through graduate students and postdoctoral fellows, who apply their specialized expertise to business research challenges.

Deadline: continuous

Read More

Multiple Sclerosis Scientific Research Foundation (MSSRF) Multi-Centre Collaborative Team Grant / MSSRF Collaborative Team Grant

The MSSRF Team Grant is a funding opportunity designed to support novel MS research conducted by scientists in Canadian institutions in collaboration with other national and international experts in the field. Studies funded by the Team Grant stimulate frequent exchange of knowledge, data, and research techniques, and provides opportunities for scientific training for younger researchers. The Team Grant supports transformative research that can have significant scientific, socio-economic and health impacts.

Deadline for letter of intent: September 8, 2014

Read More

NSERC Engage Grants

Engage Grants are designed to give companies that operate from a Canadian base access to the unique knowledge and expertise available at Canadian universities. These grants are intended to foster the development of new research partnerships between an academic researcher and a company that have never collaborated before, by supporting short-term research and development projects aimed at addressing a company-specific problem in the natural sciences or engineering fields.

Deadline: continuous

Read More

Paralyzed Veterans of America

The PVA Research Foundation is focused on funding projects that are grounded in basic laboratory science and the education of scientists working on breakthroughs directed toward a cure for paralysis or the secondary medical conditions, and technologies associated with spinal cord injury or disease (SCI/D). These projects should be designed to find better treatments and cures for paralysis, to support efforts to improve the quality of life of individuals with SCI/D until improved clinical treatments, technologies or cures are discovered, and to train post-doctoral fellow investigators and encourage them to specialize in the area of spinal cord research.

Deadline: September 02, 2014

Read More

Prader-Willi Syndrome Association

Prader-Willi Syndrome Association (USA) [“PWSA (USA)”] is pleased to offer grant assistance for scientific researchers with an interest in improving the lives of those with Prader-Willi syndrome (PWS).

Deadline: October 7, 2014

Read More

Progeria Research Foundation

The primary purpose of PRF in funding medical research through its research grantees is to support its mission to find the cause, treatment, and cure for Hutchinson-Gilford Progeria Syndrome.

Deadlines: October 27, 2014

Read More

Tourette Syndrome Association

The Tourette Syndrome Association requests research grant proposals from Ph.D. and M.D. researchers in basic and clinical studies on all aspects of Tourette syndrome.

Deadline for pre-proposals: September 12, 2014

Read More

Vistakon Contact Lens Research Fellowship

With support from Vistakon, the ARVO Foundation for Eye Research will provide one Contact Lens Research Fellowship, which will highlight basic research, including contact lens care and cleaning requirements. Available to junior investigators who are age 45 or younger at the application deadline and have received their MD, PhD or equivalent degree after June 2004

Deadline: September 30, 2014

Read More

Wellcome Trust - Translation Fund

The aim of Translation Awards is to develop innovative and ground breaking new technologies in the biomedical area. Projects must have already demonstrated proof of principle, supported by experimental data. Applications should bridge the funding gap in commercialisation of new technologies in the biomedical area and must plan to take the product, technology or intervention to a stage at which it is sufficiently developed to be attractive to another party.

Deadline for Concept Paper: October 24, 2014

Read More

World Federation of Hemophilia Clinical Research Grant Program

The WFH's Clinical Research Grant Program provides support for international clinical investigation relating to inherited bleeding disorders.

Deadline for letter of intent: August 31, 2014

Read More

Additional Opportunties:

Western researchers can consult Pivot, a comprehensive database of grant information.

Western's Office of Research Development & Services maintains information on Funding and Opportunities.

Archived funding announcements for 2013, 2012, and 2011 are available.